Aurangabad is one of India’s critical pharmaceutical hubs. Home to 79 central pharmaceutical industrial units that employ 20,000 workers, Aurangabad serves healthcare needs globally through these companies.
Pharma companies are responsible for creating medicines and drugs that treat illnesses. In addition, they also manufacture and distribute these products.
Shreya’s Pharmaceuticals
Shreya’s Pharmaceuticals is an Indian, Russian, and CIS pharmaceutical company with operations across a number of therapeutic segments, including antibiotics, antimalarials, hepatitis medications, painkillers, and infertility treatments. Furthermore, they operate their own research and development center in Mumbai.
BioRad and Aurobindo Pharma are their main competitors; neither have secured institutional investments as of yet.
Shreya Pharmaceuticals Limited of Mumbai operates both domestic and international markets with three divisions – Shreya Amadeus, Shreya AkuCare, and Shreya BioLife – offering products in over 30 countries globally. Their manufacturing facilities can be found at Aurangabad and Roorkey, respectively, with production services available worldwide through Aurangabad and Roorkey facilities. Their commitment to quality can be seen with state-of-the-art research capabilities and efficient manufacturing units supported by dedicated, experienced professionals at their core.
Tooba Pharmaceuticals
Tooba Pharma Pvt Ltd, located in Aurangabad, Maharashtra, India, is an innovative leader in pharmaceutical medicine production, specializing in tablets and capsules. Offering products such as Tamsulosin, among many others, Tooba has earned itself a strong reputation for quality service delivery and reliability.
TPPL is a GMP-certified manufacturer of API Bulk Drugs and Intermediates with state-of-the-art manufacturing facilities, featuring strong roots in R&D to explore and develop generics using newer technologies in an environmentally friendly manner. Their headquarters is in Aurangabad – a major urban center and industrial hub that houses various pharmaceutical industries – providing easy access to markets and raw materials.
Tooba Pharmaceuticals Private Limited was established on 21 June 2008 and registered at Tooba Pharmaceuticals, First Floor 4-8-65 Nawab Pura Aurangabad, with an ISIN code of IN24724NWBA013; their authorized share capital amount to INR 20 Million while paid-up capital is INR 15.983,000.
Adora Products Pvt. Ltd.
At Adora Products Pvt. ltd MIDC AreaWalujAurangabadWaluj Aurangabad, we help businesses like Adora Products Pvt ltd MIDC AreaWalujAurangabad Waluj Aurangabad with vital B2B strategies such as digital marketing, lead generation, and expanding reach through internet-powered digital strategies such as digital marketing. By harnessing its power for them, we provide manufacturers, producers, dealers, suppliers, wholesalers, and retailers an unparalleled digital stage that showcases their offerings directly in front of an engaged target audience.
Make more informed R&D decisions with the world’s most reliable patent and licensing research platform, accessing over 2 million deals, grants, and financing trends to accelerate strategic decision-making.
A Company Report by Tofler provides an in-depth examination of Adora Products Private Limited, including financial data, ratio analysis, management structure, and shareholding pattern analysis, as well as key market indicators like revenue, profit, and margins. You can purchase this report online from their website. Adora Products Private Limited’s CIN number is U24239MH2006PTC166438, with its registered office located at 10, PURNANAND SHRIRAM COLONY SAMARTH NAGAR AURANGABAD.
Sydler Group of Companies
Sydler Remedies Private Limited is an unlisted private company specializing in pharmaceutical, herbal/nutraceutical product production as well as printing and packaging services globally. Specialized in niche pharmaceutical and herbal/nutraceutical product categories with two cutting-edge manufacturing facilities for these items, Sydler Remedies exports its products across Africa, CIS, and MENA regions.
This company was established in 2004 and is located at Waluj Midc in Mumbai. It boasts three directors – Nishikant Rajkumar Jain and Pankaj Rajkumar Jain – with its Corporate Identification Number being U24230MH2003PTC141791.
The company is a medium enterprise specializing in pharmaceutical-otc medicines and other herbal formulations with Ayurveda roots, available as tablets, capsules, and ointments for instant consumption. Their diverse product lineup has earned the trust of millions around the globe, and they are known as tablets, capsules, and creams, earning their company leadership status within their industry. They remain dedicated to innovation and continuous improvement as they focus on providing only high-quality solutions.
Associated Biotech
Associated Biotech is an established third-party pharmaceutical contract manufacturing facility. Offering products across various divisions, this third-party provider delivers all-encompassing solutions for pharmaceutical companies. Their quality assurance team ensures high-quality details without any quality gaps, adhering to stringent domestic and international quality standards to provide clients with excellent outcomes.
Biotech companies differ from traditional pharmaceutical firms by seeking ways to improve human health through medical treatments and vaccines. This may involve genetically engineering animals, such as cows that produce more milk, or altering human genes to combat specific diseases. New techniques such as gene editing also enable direct changes to be made directly within cells to activate or switch off genes that cause disease.
Transparent communication is vital to any successful collaboration. Reputable third-party pharmaceutical manufacturers prioritize openness with clients, creating a more seamless and efficient partnership. This includes setting clear communication about timelines, production processes, and regulatory standards, as well as cost structures in order to make clients aware of any unexpected expenses they might encounter during manufacturing processes.
